Regeneron Pharmaceuticals
REGN
#230
Rank
A$143.89 B
Marketcap
A$1,391
Share price
-0.19%
Change (1 day)
18.84%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): A$8.25 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$16.89 Billion. In 2025 the company made an earning of A$7.90 Billion, an increase over its 2024 earnings that were of A$7.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$8.25 B4.5%
2025 A$7.90 B9.43%
2024 A$7.22 B13.83%
2023 A$6.34 B-13.57%
2022 A$7.34 B-47.9%
2021 A$14.08 B144.75%
2020 A$5.75 B56.86%
2019 A$3.66 B-4.87%
2018 A$3.85 B22.86%
2017 A$3.14 B56.3%
2016 A$2.00 B8.55%
2015 A$1.85 B54.53%
2014 A$1.19 B11.14%
2013 A$1.07 B72.13%
2012 A$0.62 B-285.93%
2011 -A$0.34 Billion121.73%
2010 -A$0.16 Billion37.18%
2009 -A$0.12 Billion-14.6%
2008 -A$0.13 Billion-25.02%
2007 -A$0.18 Billion6.32%
2006 -A$0.17 Billion-186.52%
2005 A$0.18 B2103.7%
2004 A$8.52 M-105.66%
2003 -A$0.16 Billion-18.18%
2002 -A$0.19 Billion42.33%
2001 -A$0.13 Billion129.35%
2000 -A$56.45 Million51.87%
1999 -A$37.17 Million92.19%
1998 -A$19.34 Million66.23%
1997 -A$11.64 Million-55.49%
1996 -A$26.14 Million103.53%
1995 -A$12.85 Million-70.89%
1994 -A$44.12 Million-26.08%
1993 -A$59.68 Million114.67%
1992 -A$27.8 Million196.77%
1991 -A$9.37 Million87.88%
1990 -A$4.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B 229.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$19.10 B 122.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$16.69 B 94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.76 B 36.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$0.67 B-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.84 B-78.52%๐Ÿ‡บ๐Ÿ‡ธ USA